REFERENCE
Cangene Corporation.Cangene voluntarily recalls finished product from a single HepaGam B(Rm) manufacturing bulk lot. Media Release: 29 May 2012. Available from: URL: http://www.cangene.com
Rights and permissions
About this article
Cite this article
Cangene recalls Hep B immune globulin due to thrombosis risk. React. Wkly. 1406, 3 (2012). https://doi.org/10.2165/00128415-201214060-00006
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128415-201214060-00006